Fenghua Yang Selected Research

iodopravadoline (AM 630)

8/2021	CB2R induces a protective response against epileptic seizures through ERK and p38 signaling pathways.
12/2018	CB2R induces a protective response for epileptic seizure via the PI3K 110α-AKT signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fenghua Yang Research Topics

Disease

6	Neoplasms (Cancer) 11/2020 - 02/2009
3	Stomach Neoplasms (Stomach Cancer) 11/2020 - 10/2016
3	Carcinogenesis 11/2020 - 02/2017
2	Cardiomyopathies (Cardiomyopathy) 10/2021 - 01/2017
2	Epilepsy (Aura) 08/2021 - 12/2018
2	Reperfusion Injury 01/2021 - 03/2013
2	Neoplasm Metastasis (Metastasis) 01/2018 - 10/2016
1	Myocardial Infarction 01/2022
1	Heart Injuries 10/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021
1	Wilms Tumor (Wilm's Tumor) 01/2021
1	Aortic Valve Insufficiency (Aortic Regurgitation) 03/2020
1	Hypertrophy 03/2020
1	Nasopharyngeal Carcinoma 01/2020
1	Fever (Fevers) 08/2019
1	Hydrocephalus (Hydrocephaly) 01/2019
1	Consciousness Disorders 01/2019
1	Bacterial Meningitis 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2018
1	Central Nervous System Diseases (CNS Diseases) 12/2018
1	Retinoblastoma (Glioblastoma, Retinal) 12/2018
1	Body Weight (Weight, Body) 12/2018
1	Cardiomegaly (Heart Hypertrophy) 07/2017
1	Breast Neoplasms (Breast Cancer) 02/2017
1	Heart Failure 01/2016
1	Ischemia 03/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2009

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 01/2017
2	iodopravadoline (AM 630)IBA 08/2021 - 12/2018
2	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 08/2021 - 12/2018
2	Circular RNAIBA 11/2020 - 01/2016
1	Profilins (Profilin)IBA 01/2022
1	CB2 Cannabinoid ReceptorIBA 08/2021
1	Pilocarpine (Ocusert)FDA LinkGeneric 08/2021
1	MethyltransferasesIBA 01/2021
1	6-methyladenineIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 03/2020
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2020
1	Epstein-Barr viral capsid antigenIBA 01/2020
1	AntibodiesIBA 01/2020
1	Immunoglobulin A (IgA)IBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2019
1	shengjingIBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	EnrofloxacinIBA 12/2018
1	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2018
1	Phosphotransferases (Kinase)IBA 12/2018
1	CannabinoidsIBA 12/2018
1	SolutionsIBA 12/2018
1	Cyclin D1IBA 12/2018
1	Cyclin EIBA 12/2018
1	TOR Serine-Threonine KinasesIBA 12/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018
1	UbiquitinIBA 01/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	F-Box ProteinsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 07/2017
1	Small Interfering RNA (siRNA)IBA 02/2017
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 02/2017
1	NF-kappa B (NF-kB)IBA 02/2017
1	mouse MIRN29 microRNAIBA 10/2016
1	MicroRNAs (MicroRNA)IBA 10/2016
1	AcidsIBA 03/2013
1	Epoxide HydrolasesIBA 03/2013
1	CaveolinsIBA 03/2013
1	Thymidylate SynthaseIBA 02/2009
1	EnzymesIBA 02/2009
1	DNA (Deoxyribonucleic Acid)IBA 02/2009

Therapy/Procedure

2	Therapeutics 01/2018 - 02/2009
1	Injections 11/2020
1	Oral Administration 12/2018